Literature DB >> 14178035

EPIDEMIOLOGICAL BASIS OF TUBERCULOSIS ERADICATION. 2. DYNAMICS OF TUBERCULOSIS MORBIDITY AND MORTALITY.

O HORWITZ, C E PALMER.   

Abstract

In most countries there have been signs in recent years of an accelerated decline in tuberculosis, but only the most superficial knowledge exists of what underlies the remarkable changes. It is therefore imperative to document the changing picture of tuberculosis by means of parameters that are not only descriptive but will also serve as guidelines for the development of methods to eradicate the disease.The authors describe the present system of tuberculosis reporting and control in Denmark, where the requisite conditions for obtaining meaningful statistics are, to a large extent, fulfilled, discussing its potentialities for depicting the forces behind the recent changes and pointing out its inherent deficiencies.The advantages of the Danish system, in which rates for the prevalence and incidence of respiratory tuberculosis are broken down into those for new cases and those for relapses, are stressed, as is the significance of the recently introduced practice of reporting cures and thus obtaining cure rates on a nation-wide scale.As an indicator of the lethal effect of tuberculosis in a country, the mortality rate suffers from several limitations, which will play an increasingly important role as the downward trend in tuberculosis continues. The authors suggest that a more objective measure than the specific mortality rate would be the so-called "lethality index" - an index based on all deaths occurring among persons with active tuberculosis, irrespective of whether they were attributed directly to the disease.

Entities:  

Keywords:  COMMUNICABLE DISEASE CONTROL; DENMARK; INTERNATIONAL AGENCIES; MORBIDITY; MORTALITY; TUBERCULOSIS

Mesh:

Year:  1964        PMID: 14178035      PMCID: PMC2554840     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Frequency of tuberculous infection among school children in Praesto County, with an addendum on the tuberculin testing method.

Authors:  B GROTH-PETERSEN
Journal:  Acta Tuberc Pneumol Scand       Date:  1963

2.  Epidemiological basis of tuberculosis eradication in an advanced country.

Authors:  E GROTH-PETERSEN; J KNUDSEN; E WILBEK
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

  2 in total
  8 in total

1.  [Not Available].

Authors: 
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

2.  On the epidemiology of tuberculosis in some selected countries. Highlights and prospects for control and eradication. II.

Authors:  M H Zaki
Journal:  Am J Public Health       Date:  1971-04       Impact factor: 9.308

3.  [Tuberculosis mortality in Stuttgart, 1957-1961].

Authors:  G Kerntke
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1965-12-30

4.  [New approaches to tuberculosis. Epidemiologic viewpoints].

Authors:  G Neumann
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1965-12-28

5.  Epidemiological basis of tuberculosis eradication. 3. Risk of pulmonary tuberculosis after human and bovine infection.

Authors:  K Magnus
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

6.  Epidemiological basis of tuberculosis eradication. 7. Application of life-table methods for assessing the prognosis for tuberculosis patients.

Authors:  E Iversen
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

7.  Epidemiological basis of tuberculosis eradication. 8. Some factors of significance for the prognosis for a tuberculosis patient.

Authors:  E Iversen
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

Review 8.  Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review.

Authors:  Edine W Tiemersma; Marieke J van der Werf; Martien W Borgdorff; Brian G Williams; Nico J D Nagelkerke
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.